| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/30/2008 | EP1881975A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/30/2008 | EP1881974A2 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections |
| 01/30/2008 | EP1881966A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides |
| 01/30/2008 | EP1881965A1 2-amino-4-phenylquinazoline derivates and their use as hsp90 modulators |
| 01/30/2008 | EP1881830A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility |
| 01/30/2008 | EP1689350B1 Use of osteopontin in dental formulations |
| 01/30/2008 | CN101115748A Acetamide compounds as fungicides |
| 01/30/2008 | CN101115741A 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters |
| 01/30/2008 | CN101115740A Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 01/30/2008 | CN101115739A Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidine-1-carboxylic acid derivatives and related compounds |
| 01/30/2008 | CN101115738A Pyrazolylamino substituted quinazoles for the treatment of cancer |
| 01/30/2008 | CN101115737A Novel salt form of a dopamine agonist |
| 01/30/2008 | CN101115736A Potassium channel modulating agents and their medical use |
| 01/30/2008 | CN101115734A Spiro derivatives as lipoxygenase inhibitors |
| 01/30/2008 | CN101115732A Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 01/30/2008 | CN101115727A Compounds useful for inhibiting chk1 |
| 01/30/2008 | CN101115718A N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid TRPV1 receptor ligands |
| 01/30/2008 | CN101115717A Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 01/30/2008 | CN101115715A Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 01/30/2008 | CN101115482A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 01/30/2008 | CN100364990C Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds |
| 01/30/2008 | CN100364989C Prazole derivative and its salt and use |
| 01/30/2008 | CN100364988C Indazole having analgesic activity |
| 01/30/2008 | CN100364987C Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
| 01/30/2008 | CN100364978C Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/29/2008 | US7323570 Substituted imidazoles and thiazoles; 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl)methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile,antitumor agents |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323475 Adjust concentration of erythropoietin in blood; strokes; antiepileptic agents; liver disorders; antiulcer agents; central nervous system disorders |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323470 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323464 Kinase inhibitors; autoimmune disease; antiinflammatory agents |
| 01/29/2008 | US7323460 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors |
| 01/29/2008 | US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | CA2297417C Derivatives of acyl-piperazinyl-pyrimidines, their preparation and application as medicaments |
| 01/29/2008 | CA2294347C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/24/2008 | WO2008011611A2 Compounds and compositions as itpkb inhibitors |
| 01/24/2008 | WO2008011499A1 Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 01/24/2008 | WO2008011392A2 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 01/24/2008 | WO2008011176A2 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 01/24/2008 | WO2008011117A2 Antiviral protease inhibitors |
| 01/24/2008 | WO2008011109A2 Substituted pyridone compounds and methods of use |
| 01/24/2008 | WO2008010897A2 Process for making 3-substituted 2-amino-5-halobenzamides |
| 01/24/2008 | WO2008010433A1 Bridged cyanine compounds and optical recording materials containing the same |
| 01/24/2008 | WO2008010315A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/24/2008 | WO2008009758A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 01/24/2008 | WO2008009750A2 Macrocyclic compounds useful as bace inhibitors |
| 01/24/2008 | WO2008009734A1 Macrocyclic lactams |
| 01/24/2008 | WO2008009691A1 Pyrimidine derivatives and their use as pesticides |
| 01/24/2008 | WO2008009435A1 Amino-piperidine derivatives as cetp inhibitors |
| 01/24/2008 | WO2008009406A1 Novel pyridazine derivatives |
| 01/24/2008 | WO2008009405A2 Novel pyridazine derivatives |
| 01/24/2008 | WO2008009215A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 01/24/2008 | WO2008009210A1 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases |
| 01/24/2008 | WO2008009078A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| 01/24/2008 | WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 01/24/2008 | WO2007135562A3 Hydroxyphenyl derivatives and biological applications thereof |
| 01/24/2008 | WO2007135131A8 Substituted pyrazinone derivatives for use as a medicine |
| 01/24/2008 | WO2007128086A3 Novel viral replication inhibitor |
| 01/24/2008 | WO2007126957A3 New compounds |
| 01/24/2008 | WO2007106670A3 N-formyl hydroxylamine compounds |
| 01/24/2008 | WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 01/24/2008 | WO2007066185A3 Polymorphs of a c-met/hgfr inhibitor |
| 01/24/2008 | WO2007001975A8 Piperidine derivatives useful as histamine h3 antagonists |
| 01/24/2008 | US20080021217 Heterocyclic inhibitors of rho kinase |
| 01/24/2008 | US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/24/2008 | US20080021175 Compositions and methods for polymer composites |
| 01/24/2008 | US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders |
| 01/24/2008 | US20080021081 e.g. 4'-2-{[(2S)-2-methylpyrrolidin-1-yl]methyl}cyclopropyl)-1,1'-biphenyl-4-carbonitrile; histamine-3 receptor ligand; neuroleptic agent, neurodegenerative diseases, cognition activator; attention-deficit hyperactivity disorder, schizophrenia, Alzheimer's disease, epilepsy, seizures, allergic rhinitis |
| 01/24/2008 | US20080021070 Pyridine derivatives, preparation and therapeutic application thereof |
| 01/24/2008 | US20080021069 Receptor Function Regulating Agent |
| 01/24/2008 | US20080021066 Iap inhibitors |
| 01/24/2008 | US20080021064 Novel cyclic compound having quinolylalkylthio group |
| 01/24/2008 | US20080021054 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 01/24/2008 | US20080021053 Heterocyclic Derivatives |
| 01/24/2008 | US20080021050 Compounds, compositions, and methods |
| 01/24/2008 | US20080021043 Piperidines and Related Compounds for Treatment of Alzheimer's Disease |
| 01/24/2008 | US20080021035 Myosin light chain kinase inhibitor compounds, compostions and related methods of use |
| 01/24/2008 | US20080021030 Substituted Pyrazoles As Ppar Agonists |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
| 01/24/2008 | US20080021028 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis |
| 01/24/2008 | US20080021027 Novel benzimidazole derivatives |
| 01/24/2008 | US20080021014 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 01/24/2008 | US20080021011 Therapeutic compounds |
| 01/24/2008 | US20080021010 2,4-dichloro-N-{[1- (propylsulfonyl)-3-pyridin-2- ylazetidin-3- yl]methyl}benzamide; neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction |
| 01/24/2008 | US20080021005 Pegylated Ion Channel Modulating Compounds |
| 01/24/2008 | US20080020038 Amorphous Aripiprazole and Process for the Preparation thereof |
| 01/24/2008 | US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis |
| 01/24/2008 | US20080018237 Nitrogen-containing heterocyclic derivatives and organic electroluminescence device using the same |
| 01/24/2008 | US20080016674 Method And Installation Means For Installing An Electrical Machine |
| 01/24/2008 | CA2658376A1 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexane-1-derivatives having effects of the opioid receptor system |
| 01/24/2008 | CA2658342A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/24/2008 | CA2658327A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 01/24/2008 | CA2658254A1 Novel pyridazine derivatives |
| 01/24/2008 | CA2657936A1 Antiviral protease inhibitors |
| 01/24/2008 | CA2657930A1 Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 01/24/2008 | CA2657850A1 Novel pyridazine derivatives |